The principal results of the International Immune Tolerance Study: a randomized dose comparison.

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1538-7836.2008.03270.x

Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

https://www.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1538-7836.2011.04611.x

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ri Liesner, Savita Rangarajan, Kate Talks, Mike Williams and Charles R. Hay School of Medicine, Cardiff University, University Hospital of Wales, Wales, Royal Hospital for Sick Children, Glasgow, The London School of Medicine and Dentistry, Royal London Hospital, Barts, Queen Mary University, London, Great Ormond Street NHS Trust, London, Hampshire Hospital NHS Foundation Trust, Basingstoke & North Hampshire Hospital, Basingstoke, Royal Victoria Infirmary, Newcastle upon Tyne, Birmingham Childrens’ Hospital NHS Foundation Trust, Birmingham and Central Manchester University Hospitals, Manchester, UK

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.12091

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1538-7836.2008.03032.x

F Hernández Navarro

Papers

Plasma and albumin-free recombinant factor VIII: Pharmacokinetics, efficacy and safety in previously treated pediatric patients

Cryopreservation of hematopoietic progenitor cells

Protocolo diagnóstico de la neutrofilia

Association of multiple myeloma and autoimmune hemolytic anemia

Protocolo diagnóstico de lsa anemias hemolíticas